RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

WITHDRAWN

Columbia University Irving Medical Center, New York

RECRUITING

University of Rochester, Rochester

RECRUITING

Children's Hospital of Philadelphia, Philadelphia

RECRUITING

UNC Chapel Hill, Chapel Hill

RECRUITING

Medical University of South Carolina, Charleston

RECRUITING

Emory University, Atlanta

RECRUITING

Clinica Universitaria de Navarra, Pamplona

RECRUITING

Mayo Clinic, Jacksonville

ACTIVE_NOT_RECRUITING

University of Florida Health, Gainesville

RECRUITING

University of Minnesota, Minneapolis

RECRUITING

Northwestern Memorial Hospital, Chicago

RECRUITING

The University of Chicago Medical Center, Chicago

RECRUITING

University of Kansas Medical Center, Kansas City

RECRUITING

University of Texas MD Anderson Cancer Center, Houston

RECRUITING

University of California Irvine, Orange

RECRUITING

UC Davis Health, Sacramento

RECRUITING

Yale University, New Haven

RECRUITING

Tufts Medical Center, Boston

RECRUITING

Massachusetts General Hospital, Boston

RECRUITING

Boston Children's Hospital, Boston

RECRUITING

Brigham and Women's Hospital, Boston

RECRUITING

UMass Memorial Hospital, Worcester